Clinicians have often pondered if cancer cells could be selectively targeted, and how payloads ranging from fluorescent dyes to oncology drugs could be accurately delivered to these cells, and then safely cleared through the kidneys. Now, researchers at Memorial Sloan Kettering Cancer Center, and Nanotechnology in the College of Engineering at Cornell University have found the answer in the form of a new class of ultra-small nanoparticles that are showing significant potential for cancer diagnosis and treatment, and positive results in pre-clinical and clinical trials.
Researchers are finding that the use of new ultra-small nanoparticles called C-dots allows improved visualization in Positron Emission Tomography (PET) scans for diagnosis and real-time image-guided intraoperative mapping of nodal metastases to aid in precise surgical excision, currently in Phase II human clinical trials.
These ultra-small particles can also serve as a precision therapeutic solution, targeting and penetrating cancer cells to deliver a range of cancer-killing drugs, with the promise of unused particles and the drugs they carry safely leaving the body through the renal system.
The architecture of the C-dot is an ultra-small silica nanoparticle with a diameter of less than 10 nanometers, first innovated at Cornell University by Ulrich Wiesner, the Spencer T. Olin Professor of Engineering. Silica, also known as silicon dioxide (SiO2), is a widely existing inorganic composition which can be found in many places, e.g. plants, cosmetics, medicine and food such as bread crust.
Multiple near infrared (near-IR) fluorescent dye molecules can be covalently encapsulated inside the silica particle, and the fluorescence brightness of these molecules is further enhanced by the rigid surrounding silica matrix. As a result, the overall fluorescence brightness of C-dots can be one order of magnitude higher than that of dyes alone, delivering new capabilities to surgeons. Meanwhile, the surface of C-dots is covalently covered with polymer chains to increase bio-compatibility. Due to the high versatility of the synthesis chemistry of C-dots, different functional ligands can be selectively attached to the end of some of the polymer chains on the C-dot surface to endow the particles with a variety of functionalities for different applications, including, but not limited to cancer targeting, radio-isotopes chelating, and small molecule drug delivery.
Importantly, the ultra-small hydrodynamic size of C-dots enable them to be efficiently cleared from the body through the renal system.
Image Credit: Elucida Oncology
News This Week
For about one in 13 children in the U.S., normally harmless foodstuffs such as milk, eggs and peanuts can send the body's natural defenses into overdrive. Symptoms of food allergies can vary widely, but at [...]
Frank Boehm (Nanoapps Medical Inc. Founder) has contributed to 'Platelet-Rich Plasma Applications for Achilles Tendon Repair: A Bridge between Biology and Surgery', published by International Journal of Molecular Sciences/ MDP. Abstract: Achilles tendon ruptures [...]
Using both mouse and human brain tissue, researchers at Yale School of Medicine have discovered that SARS-CoV-2 can directly infect the central nervous system and have begun to unravel some of the virus’s effects on [...]
A deep learning algorithm developed at MIT has discovered new antibiotics that can treat drug-resistant diseases by killing 35 powerful bacteria. The pathogens that the halicin antibiotic has targetted include Acinetobacter baumannii, which was nicknamed [...]
In our transforming world, digital technology has the critical mass to push our frontiers and release unlimited potential. As the wave of digital transformation soars high, improving our lives, industries and economies, we must not [...]
Scientists Discover a Way to Control the Immune System’s “Natural Killer” Cells With “Invisible” Stem Cells
UC San Francisco scientists have discovered a new way to control the immune system’s “natural killer” (NK) cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection. The [...]
A team led by scientists at Georgia State University simulates the precise transition between the processes of DNA synthesis and proofreading DNA replication is one of the most important processes in biology, responsible for ensuring [...]
Everybody loves Neandertals, those big-brained brutes we supposedly outcompeted and ultimately replaced using our sharp tongues and quick, delicate minds. But did we really, though? Is it mathematically possible that we could yet be them, [...]
From a small discovery to producing at scale, photojournalist David Levene documents the groundbreaking work of the scientists of Oxford University during the development of a vaccine which is now poised for approval by medicines regulators. [...]
Optical tweezers are a rapidly growing technology, and have opened up a wide variety of research applications in recent years. The devices operate by trapping particles at the focal points of tightly focused laser beams, [...]
In what is believed to be a medical first, researchers from Johns Hopkins Medicine (JHM) and the Johns Hopkins University Applied Physics Laboratory (APL) have enabled a quadriplegic man to control a pair of prosthetic [...]
Antibodies are remarkable biomarkers: they are the cues that provide us with indications about many diseases and how our immune system counter them. Now a group of scientists from the University of Rome, Tor Vergata [...]
Scientists used human white blood cell membranes to carry two drugs, an antibiotic and an anti-inflammatory, directly to infected lungs in mice. The nano-sized drug delivery method developed at Washington State University successfully treated both [...]